AI assistant
Sending…
RESMED INC — Director's Dealing 2013
May 21, 2013
30071_dirs_2013-05-21_e41ae380-58cf-4171-8e95-eb4ff6153371.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2013-05-17
Reporting Person: ROBERTS CHRISTOPHER G (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-05-17 | ResMed Common Stock | M | 12000 | $23.095 | Acquired | 42000 | Direct |
| 2013-05-17 | ResMed Common Stock | M | 48000 | $12.738 | Acquired | 90000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-05-17 | ResMed Stock Options | $23.095 | M | 12000 | Disposed | 2013-11-10 | ResMed Common Stock (12000) | Direct |
| 2013-05-17 | ResMed Stock Options | $12.738 | M | 48000 | Disposed | 2014-07-02 | ResMed Common Stock (48000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| ResMed Common Stock | 272400 | Indirect |
| ResMed Common Stock | 23200 | Indirect |
| ResMed Common Stock | 136000 | Indirect |
Footnotes
F1: Represents date options first became exercisable. Options vest 1/12 each month until fully vested.
F2: Represents date first became exercisable. Options vest 1/3 each year on the anniversary of the grant.
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Earnings Release
2026
Jan 29